10 leading stroke scientists to receive American Stroke Association honors, including the Ralph L. Sacco Outstanding Stroke Research Mentor Award

If anything here points to getting survivors 100% recovered I don't see it and these are not valid honors.  As far as I can tell Dr. Sacco did nothing to advance survivor recovery. They can't be leading scientists. LEADERS DELIVER STROKE RECOVERY!

Please point EXACTLY to the interventions Dr. Sacco initiated that got survivors fully recovered. I take no prisoners in advancing stroke recovery and exposing naked emperors. 

What is Dr. Sacco's impact factor in getting survivors recovered?

10 leading stroke scientists to receive American Stroke Association honors, including the Ralph L. Sacco Outstanding Stroke Research Mentor Award 

American Stroke Association International Stroke Conference 2023

AddThis Sharing Buttons

Embargoed until 8 a.m. CT/9 a.m. ET, Tuesday, February 7, 2023

DALLAS, February 7, 2023 – Ten scientists leading the way in stroke research will be recognized for their exceptional achievements during the American Stroke Association’s International Stroke Conference 2023, to be held in person in Dallas and virtually Feb. 7-10. The world’s premier meeting for researchers and clinicians is dedicated to the science of stroke and brain health.

The illustrious group of awardees includes four groundbreaking scientists who have devoted their careers to stroke research, including the recipient of the newly renamed Ralph L. Sacco Outstanding Stroke Research Mentor Award. The award was renamed to honor Dr. Sacco, a past president of the American Heart Association and American Stroke Association, who passed away on Jan. 17. The award honors Dr. Sacco’s exceptional contributions to the field of stroke research and to the Association, as well as his instrumental role as a leading stroke mentor throughout his career. Six more scientists will be honored for their notable new research.

The honorees are:

• Cheryl Bushnell, M.D., M.H.S., FAHA, Wake Forest University School of Medicine in Winston Salem, North Carolina, will receive the Edgar J. Kenton III Lecture Award.
• Cheryl Bushnell, M.D., M.H.S., FAHA, Wake Forest University School of Medicine in Winston Salem, North Carolina, also will receive the Ralph L. Sacco Outstanding Stroke Research Mentor Award.
• Zena Vexler, Ph.D., University California San Francisco, Weill Institute for Neurosciences in San Francisco, will be awarded the Thomas Willis Lecture Award.
• George Howard, Dr.P.H., University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, will receive the David G. Sherman Lecture Award.
• José Biller, M.D., FAHA, Loyola University Chicago Stritch School of Medicine, Loyola University Health System in Maywood, Illinois, will be honored with the William M. Feinberg Award for Excellence in Clinical Stroke.
• Daniela Renedo, M.D., Yale School of Medicine in New Haven, Connecticut, will receive the Stroke Basic Science Award.
• Shun-Ming Ting, M.Sc., University of Texas Health Science Center at Houston, will receive the Mordecai Y.T. Globus New Investigator Award.
• Kyle Kern, M.D., M.S., National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health, in Bethesda, Maryland, will receive the Vascular Cognitive Impairment Award.
• Brian Mac Grory, M.B., B.Ch., B.A.O., FAHA, Duke University School of Medicine in Durham, North Carolina, will receive the Stroke Care in Emergency Medicine Award.
• Kent Simmonds, D.O., Ph.D., UT Southwestern Medical Center in Dallas, will be awarded the Stroke Rehabilitation Award.
• Eva A. Mistry, M.B.B.S., M.S.C.I., FAHA, University of Cincinnati in Ohio, will receive this year’s Robert G. Siekert New Investigator Award in Stroke.

Cheryl Bushnell, M.D., M.H.S., FAHA, the winner of the Edgar J. Kenton III Lecture Award, is a professor of neurology, vice chair of research, Stroke Division chief and co-director of the Neuroscience Clinical Trial and Innovation Center at Wake Forest University School of Medicine in Winston Salem, North Carolina. Bushnell is passionate about inpatient and outpatient stroke treatment across the continuum, especially the transition of post-acute care and secondary prevention. Her research spans women’s issues related to stroke including sex differences in risk and outcomes. She also served as chair of the first AHA Guideline for the Prevention of Stroke in Women. The Edgar J. Kenton III Lecture Award recognizes lifetime contributions to the investigation, management, mentorship and community service in the field of racial and ethnic stroke disparities or related disciplines. Bushnell will present her Edgar J. Kenton III lecture, “Achieving BP Goals and Addressing Inequities in BP Management after Stroke: It All Starts with Stakeholder Engagement,” at 9:30 a.m. CT, Tuesday, February 7.

Cheryl Bushnell, M.D., M.H.S., FAHA, also is the recipient of the newly renamed Ralph L. Sacco Outstanding Stroke Research Mentor Award. The Stroke Research Mentor Award recognizes outstanding achievements in mentoring future generations of stroke researchers in the field of cerebrovascular disease. Throughout her career, Bushnell has mentored undergraduate and medical students, neurology residents, stroke fellows, junior faculty and nurse practitioners on stroke research projects. Bushnell will present her lecture, “Stroke Research and Academic Learning Health Systems: Mentoring Challenges and Opportunities,” at 11:19 a.m. CT, Thursday, February 9.

Zena Vexler, Ph.D., the  winner of the Thomas Willis Lecture Award, is professor and director of research at the Neonatal Brain Disorders (NBD) Center in the department of neurology at the University California, San Francisco and Weill Institute for Neurosciences in San Francisco. The Thomas Willis Award recognizes contributions to the investigation and management of stroke basic science. Vexler’s research interests include the mechanisms of perinatal arterial ischemic stroke (PAIS) and childhood arterial ischemic stroke (CAIS), and how brain maturation at the time of stroke affects brain injury and repair. She has been an editorial board member for several journals, including Stroke, the Journal of Cerebral Blood Flow and Metabolism, Fluids and Barriers of the CNS and Pediatric Research. As laboratory director and director of research for the NBD Center, she has trained more than 30 post-doctoral fellows and physician scientists from around the world. Vexler’s lecture, “Immune-neurovascular Interactions in Experimental Perinatal and Childhood Stroke,” will be presented at 11:30 a.m. CT, Wednesday, February 8.

George Howard, Dr.P.H., the winner of the David G. Sherman Lecture Award, is a Professor of Biostatistics at the University of Alabama at Birmingham. He received his training in biostatistics from the University of North Carolina at Chapel Hill. The Sherman Award honors David G. Sherman, M.D., a prominent stroke physician and an internationally recognized leader and researcher in stroke prevention and treatment. The award recognizes lifetime contributions to the investigation, management, mentorship and community service in the stroke field. Howard’s extensive experience includes biostatistics, cerebrovascular/cardiovascular epidemiology, data management and the direction of coordinating centers of multicenter studies. His career has a dual focus of observational studies in cardiovascular epidemiology (with a recent focus to understand and reduce disparities in stroke and other cardiovascular diseases), and in the direction of coordinating centers for multi-center, randomized clinical trials. Howard will present his lecture, “Reducing the Disparities in Stroke. Have We Been Aiming at the Right Targets?” at 11:02 a.m. CT, Thursday, February 9.

José Biller, M.D., FAHA, the awardee of the William M. Feinberg Award for Excellence in Clinical Stroke, is professor of neurology and neurological surgery and chairperson of the department of neurology at Loyola University Chicago’s Stritch School of Medicine at Loyola University Health System in Maywood, Illinois. The William M. Feinberg Award for Excellence in Clinical Stroke is named for the prominent stroke clinician-researcher and American Heart Association volunteer who contributed to a more comprehensive understanding of the causes of stroke. The award recognizes significant contributions to the investigation and management of clinical research in stroke. Biller is the recent past chief editor of the Journal of Stroke and Cerebrovascular Diseases, past chief editor of Frontiers in Neurology, and an editorial board member and reviewer for an array of other national and international journals and publications. He has published hundreds of peer-reviewed articles and book chapters and given more than 750 lectures around the world. Biller’s lecture, “Identifying Stroke Mimics, Chameleons, and Beyond: A visual overview,” will be presented at 11:02 a.m. CT, Friday, February 10.

Daniela Renedo, M.D., the winner of the Stroke Basic Science Award, is a postdoctoral research fellow working in the departments of neurosurgery and neurology at the Yale School of Medicine in New Haven, Connecticut, co-mentored by Dr. Charles Matouk and Dr. Guido Falcone. She completed her medical degree at Austral University School of Medicine followed by neurosurgery residency at the Hospital de Clinicas “Jose de San Martin,” both in Buenos Aires, Argentina. Then, she emigrated to the United States to pursue advanced research training in population genetics, genomic medicine, data sciences and single-cell analysis. Supported by a grant from the American Heart Association, Renedo’s work focuses on understanding the socioeconomic and biological underpinnings of neurovascular diseases. The Stroke Basic Science Award recognizes outstanding basic or translational science that is laboratory-based. Renedo’s winning presentation (Abstract 15), “Single-cell Immune Landscape of Human Clot Retrieved at Mechanical Thrombectomy: Association with Stroke Origin,” will be presented at 7:30 a.m. CT, Wednesday, February 8.

Shun-Ming Ting, M.Sc., the Mordecai Y.T. Globus New Investigator Award in Stroke winner, is a Ph.D. student in neuroimmunology at the University of Texas Health Science Center at Houston. This award recognizes Globus’ major contributions to research in cerebrovascular disease and his outstanding contributions to the elucidation of the role of neurotransmitters in ischemia and trauma; the interactions among multiple neurotransmitters; mechanisms of hypothermic neuroprotection; and the role of oxygen radical mechanisms and nitric oxide in brain injury. Ting’s award-winning presentation (Abstract 16), “Retinoid X Receptors (RXR) Play Essential Roles in Improving Post-ischemic Stroke Recovery in Aged Brain by Restoring Age-associated Dysfunctions of Microglia/macrophages” will be presented at 7:42 a.m. CT, Wednesday, February 8.

Kyle Kern, M.D., M.S., is the Vascular Cognitive Impairment Award recipient. He is  a clinical research fellow in the intramural stroke branch of the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health in Bethesda, Maryland. The Vascular Cognitive Impairment Award encourages investigators to undertake or continue research or clinical work in the field of vascular cognitive impairment and submit an abstract to the International Stroke Conference. Kern’s award-winning presentation (Abstract 55), “Intensive Blood Pressure Treatment Remodels Brain Perivascular Spaces: A Secondary Analysis of The SPRINT MIND Trial,” will be presented at 3:30 p.m. CT, Wednesday, February 8.

Brian Mac Grory, M.B., B.Ch., B.A.O., FAHA, the winner of the Stroke Care in Emergency Medicine Award, is an associate professor of neurology & ophthalmology at Duke University School of Medicine in Durham, North Carolina. The Stroke Care in Emergency Medicine Award encourages investigators to undertake or continue research in the emergent phase of acute stroke treatment and submit an abstract to the International Stroke Conference. Mac Grory’s winning presentation (Abstract 67), “Endovascular Thrombectomy in Patients with Acute Ischemic Stroke and Recent Use of Oral Vitamin K-Antagonists: The Get With The Guidelines-Stroke Program” will be presented at 7:30 a.m. CT, Thursday, February 9.

Kent Simmonds, D.O., Ph.D., the  Stroke Rehabilitation Award winner, is a second-year resident at UT Southwestern Medical Center in Dallas, Texas. The Stroke Rehabilitation Award encourages investigators to undertake or continue research and/or clinical work in the field of stroke rehabilitation. Simmonds’ winning presentation (Abstract 146), “Racial Disparities in The Treatment of Post-stroke Complications Among Acute Stroke Patients,” will be presented at 9:15 a.m. CT, Friday, February 10.

Eva A. Mistry, M.B.B.S., M.S.C.I., FAHA, the winner of the Robert G. Siekert New Investigator Award in Stroke, is an assistant professor of clinical neurology and rehabilitation medicine at the University of Cincinnati in Ohio. The Siekert New Investigator Award in Stroke recognizes Robert G. Siekert, who was the founding chairman of the American Heart Association’s International Conference on Stroke and Cerebral Circulation, now known as the International Stroke Conference. The award encourages new investigators to undertake or continue stroke-related research. Mistry’s award-winning presentation (Abstract LB18), “Blood Pressure After Endovascular Stroke Treatment (BEST)-II: A Randomized Clinical,” will be presented at 11:17 a.m. CT, Friday, February 10.

Statements and conclusions of studies presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policies or positions. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed; rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.

The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.

Additional Resources:

• Multimedia is available on the right column of the release link https://newsroom.heart.org/news/10-leading-stroke-scientists-to-receive-american-stroke-association-honors-including-the-ralph-l-sacco-outstanding-stroke-research-mentor-award?preview=3869b188ad8180eb9f4e28cebeee6f49
• Link to abstract; and ASA’s International Stroke Conference 2023 Online Program Planner
• For more news at ASA International Stroke Conference 2023, follow us on Twitter @HeartNews #ISC23

The American Stroke Association’s International Stroke Conference (ISC) is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. ISC 2023 will be held in person in Dallas and virtually, Feb. 8-10, 2023. The three-day conference will feature more than a thousand compelling presentations in categories that emphasize basic, clinical and translational sciences as research evolves toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies. Engage in the International Stroke Conference on social media via #ISC23.

About the American Stroke Association

The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit stroke.org. Follow us on Facebook, Twitter.

###

For Media Inquiries and AHA Expert Perspective:

AHA Communications & Media Relations in Dallas: 214-706-1173; ahacommunications@heart.org

Renowned neurologist Ralph L. Sacco remembered for leadership, advancements in stroke

 Really? Please point EXACTLY to the interventions he initiated that got survivors fully recovered. I take no prisoners in advancing stroke recovery and exposing naked emperors. 

What is Dr. Sacco's impact factor in getting survivors recovered?

Renowned neurologist Ralph L. Sacco remembered for leadership, advancements in stroke 

Ralph L. Sacco, MD, MS, professor and chair of the department of neurology at the University of Miami Miller School of Medicine, died on Jan. 17 from glioblastoma, according to a statement from the university.

“Dr. Ralph Sacco’s work helped to cement the Miller School’s reputation and enhance Miami’s world-class standing in stroke and cardiovascular and brain health,” Henri R. Ford, MD, MHA, dean and chief academic officer of the Miller School, said in the statement. “He was a gifted researcher, a committed teacher and mentor, and an irreplaceable friend who was part of the nucleus of our institution.”

A native of New Jersey, Sacco attended Boston University School of Medicine, where he assisted his mentor in the Framingham Heart Study, the country’s longest-running longitudinal analysis of risk for cardiovascular disease. Sacco later joined the faculty at Columbia University, where he founded the Northern Manhattan Stroke Study, an examination of underserved and understudied Black and Latino populations.

Ralph Sacco

Sacco founded and served as executive director of the Florida Stroke Registry and founding principal investigator of the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities and the Family Study of Stroke Risk and Carotid Atherosclerosis, according to the university statement.

In addition to chairing the department of neurology at the Miller School of Medicine, Sacco was the Olemberg Family Chair in Neurological Disorders, chief of neurology at Jackson Memorial Hospital and executive director of the Evelyn F. McKnight Brain Institute. He also directed and served as multi-principal investigator at the Miami Clinical and Translational Science Institute.

Sacco served as president of the American Academy of Neurology (AAN) from 2017 to 2019 and was the first neurologist to become president of the American Heart Association (AHA), a position he held from 2010 to 2011. Sacco was the only physician to be named head of both professional organizations.

A fellow of the Stroke and Epidemiology Councils of the AHA, the AAN and the American Neurological Association, Sacco also sat on the board of directors of the World Stroke Organization (WSO). He served as editor-in-chief of the AHA’s peer-reviewed scientific journal Stroke.

Sacco received numerous awards and distinctions throughout his career, notably the WSO’s Global Leadership Award and the AHA’s Gold Heart Award, Distinguished National Leadership Award and 2022 Distinguished Scientist Award. At its chair summit in December, the AAN announced the event would be renamed the Ralph L. Sacco Neurology Chair Summit, according to the university statement.

“Ralph was one of a kind,” AHA and American Stroke Association CEO Nancy Brown said in a joint statement from the groups. “His leadership was unparalleled, and his warm, generous heart and care transcended his research and clinic to every person fortunate to meet him and likely become a friend.

“The association is forever grateful that he chose to share his time and extraordinary talents with us, and we will continue to honor his memory through the work we do to champion health equity and brain health resulting in longer, healthier lives for all people.”

Reference:

• American Heart Association grieves the loss of past president Ralph L. Sacco, MD, MS, FAHA, FAAN. https://newsroom.heart.org/news/american-heart-association-grieves-the-loss-of-past-president-ralph-l-sacco-m-d-m-s-faha-faan. Accessed Jan. 18, 2023.
• Avitzur O. Stroke. 2022;doi:org/10.1161/STR.0000000000000423.
• Remembering Dr. Ralph L. Sacco. https://physician-news.umiamihealth.org/remembering-dr-ralph-l-sacco/. Published Jan. 18, 2023. Accessed Jan. 20, 2023.

Regional cerebral blood perfusion changes in chronic stroke survivors as potential brain correlates of the functional outcome following gamified home-based rehabilitation (IntelliRehab)—a pilot study

Not sure what this is trying to say, incomprehensible to me. I guess I'm not smart enough to understand stroke research, which obviously means I should not be commenting on stupid stroke research. So my 24,330 posts on stroke are all invalid. Guess I should just shut up and let stroke continue to fail survivors spectactularly. But I will persevere anyway since someone needs to tell the stroke medical world they are all naked.

Regional cerebral blood perfusion changes in chronic stroke survivors as potential brain correlates of the functional outcome following gamified home-based rehabilitation (IntelliRehab)—a pilot study

• Younis M. S. Firwana,
• Mohd Khairul Izamil Zolkefley,
• Hasnetty Zuria Mohamed Hatta,
• Christina Rowbin,
• Che Mohd Nasril Che Mohd Nassir,
• Muhammad Hafiz Hanafi,
• Mohd Shafie Abdullah,
• Bilgin Keserci,
• Natasha A. Lannin &
• Muzaimi Mustapha 

Journal of NeuroEngineering and Rehabilitation volume 19, Article number: 94 (2022) Cite this article

• 1 Altmetric

• Metrics details

Abstract

Background

Hospital-based stroke rehabilitation for stroke survivors in developing countries may be limited by staffing ratios and length of stay that could hamper recovery potential. Thus, a home-based, gamified rehabilitation system (i.e., IntelliRehab) was tested for its ability to increase cerebral blood flow (CBF), and the secondary impact of changes on the upper limb motor function and functional outcomes.

Objective

To explore the effect of IntelliRehab on CBF in chronic stroke patients and its correlation with the upper limb motor function.

Methods

Two-dimensional pulsed Arterial Spin Labelling (2D-pASL) was used to obtain CBF images of stable, chronic stroke subjects (n = 8) over 3-months intervention period. CBF alterations were mapped, and the detected differences were marked as regions of interest. Motor functions represented by Fugl-Meyer Upper Extremity Assessment (FMA) and Stroke Impact Scale (SIS) were used to assess the primary and secondary outcomes, respectively.

Results

Regional CBF were significantly increased in right inferior temporal gyrus and left superior temporal white matter after 1-month (p = 0.044) and 3-months (p = 0.01) of rehabilitation, respectively. However, regional CBF in left middle fronto-orbital gyrus significantly declined after 1-month of rehabilitation (p = 0.012). Moreover, SIS-Q7 and FMA scores significantly increased after 1-month and 3-months of rehabilitation. There were no significant correlations, however, between CBF changes and upper limb motor function.

Conclusions

Participants demonstrated improved motor functions, supporting the benefit of using IntelliRehab as a tool for home-based rehabilitation. However, within-participant improvements may have limited potential that suggests the need for a timely administration of IntelliRehab to get the maximum capacity of improvement.

Introduction

Cerebrovascular disease (CVD) such as stroke is the third leading cause of death in the United States, Canada, Europe, and Japan. The American Heart Association and the American Stroke Association estimated that approximately 800,000 new strokes occur each year, resulting in more than 130,000 annual deaths in the U.S. alone [1]. CVD is also the second leading cause of disability-adjusted life-years (DALYs) [2]. In Malaysia, the incidence rate for both hemorrhagic and ischemic stroke has increased annually by 18.7% and 29.5% respectively, making stroke as the third leading cause of mortality [3].

Previous studies had shown that lesion localization influences the functional outcome of stroke patient, hence, different infarct locations will lead to different pattens of brain injury and functional reorganization [4]. Also, the blood supply in the involved regions may be affected by the ischemic infarct that leads to tissue damage in the peri-infarct regions. Studies have demonstrated that cerebral blood flow (CBF) disruption that arises from stroke can influence the lesion areas, homologous sites in the contralesional hemisphere and even in remote regions that are generally connected to the site of injury [5,6,7,8]. Thus, abnormal CBF may have an effect on the hemodynamic response [9,10,11], and decreased CBF in neuroanatomically intact regions may still contribute to functional deficits [12]. Previous research had suggested that different CBF alteration patterns in chronic stroke patients with different infarct locations within subcortical motor pathways, potentially provide important information for the initiation of individualized rehabilitation strategies for stroke patients involving different infarct types [13].

In this study, we sought to understand the effect of IntelliRehab (which is an intelligent medical system with customized exercises for personalized home telerehabilitation) on CBF in the whole brain and the associated region of interests (ROI). The aim of this study was therefore to measure changes in the CBF patterns of different infarction locations involving the motor pathways, and its correlation on upper limb motor function.

The Big Dirty Secret Every Doctor Knows

This paragraph from there is instructive: Not being allowed to question the process. In stroke that leads to disaster where survivors haven't been progressing in decades because no one tells the emperor that he has no clothes. No one challenges the 'experts'. 

The Big Dirty Secret Every Doctor Knows

But the responsibility for eminence-based medicine goes well beyond the elite coterie of experts. The real problem is the culture of medicine, which rewards the hubris of eminence and actively punishes or offers subtle disincentives to anyone who question this process.

Why You Must Submit Your Science to the International Stroke Conference 2017

I bet no one will expose the naked emperor. The fact that there is NO strategy to solve all the problems in stroke. Everyone will just ignore the elephant in the room.
http://click.heartemail.org/?qs=1d8b859be13ecaf1c173d4eb00da59b19a7d780e0e52f14a302cb5d85b21f062

• Leaders in the stroke world will hear your science: More than 4,500 cerebrovascular experts from over 60 countries attend the International Stroke Conference.
  
  
• Be a trail blazer in the stroke field: Media coverage from around the world resulted in nearly 2 billion media impressions for ISC 2016.
  
  
• Change the stroke landscape with your science: Your science will have greater reach. ISC 2016 reached nearly 5 million people via AHA social media channels.
  
  
• Apply for Awards: AHA Members - abstract submission offers you the opportunity to apply for ISC awards.
  
  
• Publication: Accepted ISC 2017 and Nursing Symposium 2017 Abstracts will be published online in February 2017 on the AHA's Stroke journal Web site.

Abstract Submission Deadline: August 16, 2016, 11:59 pm CDT
This deadline will not be extended.

What does development of the FDA’s new patient engagement committee actually mean for patients?

This could be quite useful to us if we get someone on the committee. We need to shout to the rooftops that the stroke medical world is completely naked and needs to be ejected from any policy making in stroke.
http://medcitynews.com/2015/09/what-does-the-fdas-new-focus-on-patient-engagement-with-committee-development-actually-mean-for-patients/?utm_source=MedCity+News+Subscribers&utm_campaign=f9a8a72ed0-MCN+Medical+Devices+Weekly&utm_medium=email&utm_term=0_5092836c41-f9a8a72ed0-408818725

Robotic sperm is here, and it’s not just for fertilization — it might help treat cancer, too

This is just too damned simple, you just repurpose this to tPA delivery. Do we have anybody in the stroke world with any brains and initiative at all? You just write a request for proposal and have researchers come back with cost estimates and solution ideas and  solve the damned problem of tPA bleeding.
The argument against tPA delivery here:

Against: And just what is the emperor of stroke wearing?

Everything in that article is solvable. But they would rather do the chicken little approach.

1. Correct diagnosis of bleed vs. clot.  See the Qualcomm Tricorder X Prize

2. Bleeding out even though the stroke was accurately categorized as a clot.

This is solvable by reducing the size of the bolus thru this robotic method or directed magnetic nanoparticles.

Robotic sperm is here, and it’s not just for fertilization — it might help treat cancer, too

'Since the quick recovery did not work, you''ll have to settle for the slow rehab recovery'

The quote from my ER doctor when tPA did not fully work. This is 10 years after it was approved and very obviously this doctor had seen it fail many  times before. He should have gone screaming into the head stroke doctors office, 'That tPA barely ever works, what are you doing about something better?'  But no, no one was willing to tell the emperor that he was naked. Which means that we have wasted almost 20 years trying to shoehorn  everything into a tPA protocol. Damn are people stupid. This is why the stroke medical world should not be in charge of stroke research and rehabilitation.

The Efficacy of Stroke Rehabilitation

The efficacy is a complete failure since only 10% fully recover. There is 48 pages dancing around that fact and no mention of the 10% recovery. Damn are they good at missing the naked emperor.
The Efficacy of Stroke Rehabilitation

Dear Doctor, I want to have a stroke. How do I accomplish that?

Research has proven that mentally challenging tasks can delay or prevent dementia/Alzheimers. So ask your doctor to be a guinea pig in that experiment.

  Keeping mentally active, working or reading
Working as a doctor post stroke would be interesting, researching your 100% recovery with no doctor or stroke association help will be mentally challenging. Reading all those research papers, including those Danish, Iranian and Polish ones in their original language. Then your doctor can write a paper explaining how damned easy it is to recover from a stroke and hand deliver it to all the neurologists in your country.  Then and only then, maybe the know-it-all doctors will finally realize they are the original naked emperor.

How do you get to 100% stroke recovery?

First of all you don't ask your doctor, they have no clue.
This is the million dollar question that no one is willing to answer, your doctor, the ASA,NSA and WSO all punt on this question. They are all naked emperors.
The best way is to have a very small stroke. These people are probably the ones listed in the statistics of 10% fully recovering.
Then you look at those who seem to have succeeded in spite of the medical establishment.
Like Pedro Bach-y-Rita with his massive brain stem stroke http://oc1dean.blogspot.comR/2011/05/brainstem-stroke-recovery.html
or
Michelle Mack born with half a brain due to stroke
http://www.pbs.org/saf/1101/segments/1101-6.htm 

or Jill Bolte-Taylor whom it is impossible to tell how bad her stroke was
http://www.ted.com/talks/jill_bolte_taylor_s_powerful_stroke_of_insight.html
Or
Kathy with 26 months of hard work.
http://www.youtube.com/watch?feature=player_embedded&v=71WEEn-bU9c

Are Neurologists Respected?

From a student doctor forum, short answer - no.
http://forums.studentdoctor.net/showthread.php?t=104073
I have gone to several information sessions about Neurology. Most of the neurologists say that the "know everything, do nothing" stereotype about neurology is no longer true. They say that there are a lot of treatments available now and are developing that make neurology a good field to go into.

On the other hand, I have never heard of a non-neurologist say anything good about neurology. I have a physician sibling and she flat out told me that she doesn't respect the neurologists that she works with. She says they don't know much. Some friends who shadowed physicians say that a lot of physicians dump patients to neurology when they can't do anything with them.

So my question is: Has neurology changed for the better? Are there real procedures available in neurology? I am not interested at all in treating headaches or doing sleep related things. Secondly, are neurologists respect anywhere? Granted, my sample is small (2 people) but I have not heard any good things.

Answers at link.

My opinion, absolutely not, they are naked emperors.

Football - Heads Up: Good play or good ploy?

Safety concerns about tackling in youth football. Notice they say nothing about pretreatment like this;

Effect of fish oil supplementation in a rat model of multiple mild traumatic brain injuries

or interventions after the concussions.

Dietary Strategy to Repair Plasma Membrane After Brain Trauma Implications for Plasticity and Cognition

The NFL has enough money to employ as least one good researcher who could find and push these solutions.  But they seem to be just as naked as the medical emperors.

What is your doctor doing the first week you are in the hospital for your stroke?

This is a very serious question. If they are doing nothing then your doctor is a problem you need to solve. Demand to know what s/he is going to do about the neuronal cascade of death. Its from Jan. 2009 so that will tell you a lot about their incompetence.  I would suggest telling them they will not get paid unless they get off their ass and do something positive.
My suggestions with references are here;

What I am going to insist I get after my next stroke

Then ask your doctor how many neurons they are killing; Calculations are provided in this post.

How many neurons is your doctor responsible for killing/not saving?
Sounds like a class action suit that your neurons would have a good chance of winning if they were alive, but they were killed to make sure they couldn't testify in the RICO case.

But since I am not medically trained I should not be listened too and should never point out the nakedness of the medical emperor.


Sorry about that, I was feeling especially ranty today.
Yes, I am still outraged.